Release Date: Jun 2017
MOC: PR, SBP
Olga Kochar, MS, CSSGB
Director of Laboratory and Transfusion Services, Professor, School of Medicine and Health Sciences, The George Washington University Hospital, Washington, DC
CMS has implemented a new Individualized Quality Control Plan (IQCP) requirement as a component of the CMS CLIA survey. At this point, Histology to a very large extent remains an art and a manual process as well. We will discuss Risk Management in Histology and how to approach it in your laboratory and what are the most helpful strategies to make this assessment an effective tool for you. We will also discuss ideas on how to optimize your current QC/QA processes to ensure you provide continuous quality patient care with optimal clinical outcomes. By exchanging some Risk Management concepts, we will identify new initiatives and ongoing measures to improve the quality of patient care and patient safety in your laboratory and ultimately design a comprehensive Quality Management Plan based on Risk Assessment and overall Patient-Centric approach (or IQCP).
After attending this session, participants will be able to:
- Define risk management and its application in the histology laboratory.
- Understand common sources of error in histology and mechanisms to reduce risks.
- Discuss case study examples of risk assessment and Individual Quality Control Plans (IQCP).
- Summarize the goals of an IQCP
Who should attend? Practicing Pathologists, Laboratory Managers, Histotechnologists